Cannabis Bioscience International Holdings (CBIH) Shares Outstanding (Weighted Average) (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Shares Outstanding (Weighted Average) across 5 years of filings, most recently posting $11.6 billion for Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $11.6 billion, up 8.39% year-over-year; the trailing twelve-month figure through Feb 2026 was $11.6 billion (up 8.39% YoY), and the FY2025 annual result was $10.7 billion, up 3.86% from the prior year.
• Shares Outstanding (Weighted Average) came in at $11.6 billion for Q1 2026 at Cannabis Bioscience International Holdings, roughly flat from $11.6 billion in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $11.6 billion in Q3 2025 to a low of $8.1 billion in Q4 2022.
• The 5-year median for Shares Outstanding (Weighted Average) is $10.4 billion (2023), against an average of $10.3 billion.
• Across the five-year window, Shares Outstanding (Weighted Average) increased 27.7% in 2023 and rose 1.23% in 2024, its largest moves.
• Cannabis Bioscience International Holdings' Shares Outstanding (Weighted Average) stood at $8.1 billion in 2022, then rose by 27.7% to $10.3 billion in 2023, then grew by 1.6% to $10.5 billion in 2024, then grew by 10.76% to $11.6 billion in 2025, then changed by 0.0% to $11.6 billion in 2026.
• The last three Shares Outstanding (Weighted Average) figures came in at $11.6 billion (Q1 2026), $11.6 billion (Q4 2025), and $11.6 billion (Q3 2025), per Business Quant data.